$48.87
-0.31-0.63%
Last update: 1:21 PM
15 minutes delayed
Amphastar Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amphastar Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $0.94 | $0.77 | 22.1 % |
Mar 2024 | 2024-05-08 | $1.04 | $0.74 | 40.5 % |
Dec 2023 | 2024-02-28 | $0.88 | $0.91 | -3.30 % |
Sep 2023 | 2023-11-08 | $1.15 | $0.69 | 66.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $182.39M | $170.94M | 6.70 % |
Mar 2024 | 2024-05-08 | $171.84M | $174.90M | -1.75 % |
Dec 2023 | 2024-02-28 | $178.11M | $175.67M | 1.39 % |
Sep 2023 | 2023-11-08 | $180.56M | $174.63M | 3.39 % |
Amphastar Pharma (AMPH) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $0.94, which beat the estimate of $0.77.
The Actual Revenue was $182.4M, which beat the estimate of $170.9M.
Browse earnings estimates, EPS, and revenue on all stocks.